Darien, CT · Founded 2006 · Privately Held (backing)
Operator of a bio-pharmaceutical company intended to assist with the discovery and development of safe and innovative treatments to finally resolve moderate to severe pain. Cytogel Pharma is based in Darien, CT and was founded in 2006. It was valued at $47 million at its later-stage round in Oct 2024, the last priced event on record. It has raised $32.8 million across 4 recorded rounds; the latest was a $1.8 million seed round in Jun 2023.
PMV mark · valuation
$47.0M
Oct 2026
Priced at
its later-stage round
Oct 2024
Total raised
$32.8M
Last round
Seed Round
Jun 2023
No prints on record
No secondary trades in Cytogel Pharma shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cytogel Pharma with a free account
·Watch Cytogel Pharma: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Cytogel Pharma stock.
